Free Trial

Geode Capital Management LLC Has $60.12 Million Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Surgery Partners logo with Medical background

Geode Capital Management LLC lifted its stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 2.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,864,346 shares of the company's stock after buying an additional 42,897 shares during the period. Geode Capital Management LLC owned approximately 1.47% of Surgery Partners worth $60,117,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the stock. KBC Group NV raised its position in shares of Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company's stock valued at $77,000 after buying an additional 576 shares in the last quarter. Quarry LP increased its stake in Surgery Partners by 133.1% in the second quarter. Quarry LP now owns 3,082 shares of the company's stock valued at $73,000 after acquiring an additional 1,760 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. raised its position in Surgery Partners by 747.6% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company's stock valued at $124,000 after purchasing an additional 3,379 shares in the last quarter. Creative Planning bought a new stake in Surgery Partners during the third quarter worth $258,000. Finally, Versor Investments LP acquired a new stake in Surgery Partners in the third quarter valued at about $271,000.

Surgery Partners Trading Up 8.2 %

Surgery Partners stock traded up $1.61 during mid-day trading on Friday, hitting $21.22. 1,643,492 shares of the stock were exchanged, compared to its average volume of 999,904. The stock has a market capitalization of $2.70 billion, a price-to-earnings ratio of -44.21, a PEG ratio of 17.40 and a beta of 2.58. Surgery Partners, Inc. has a 12 month low of $19.50 and a 12 month high of $35.29. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. The firm's fifty day simple moving average is $25.99 and its two-hundred day simple moving average is $27.77.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The firm had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. During the same quarter in the previous year, the firm earned $0.15 EPS. Surgery Partners's quarterly revenue was up 14.3% on a year-over-year basis. Analysts forecast that Surgery Partners, Inc. will post 0.71 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have commented on the company. Bank of America assumed coverage on Surgery Partners in a research note on Monday, December 16th. They set a "buy" rating and a $30.00 target price for the company. Macquarie restated an "outperform" rating and issued a $34.00 target price on shares of Surgery Partners in a research report on Tuesday, November 19th. UBS Group assumed coverage on shares of Surgery Partners in a report on Monday, October 14th. They set a "buy" rating and a $38.00 price target for the company. Royal Bank of Canada reduced their price objective on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating on the stock in a research report on Wednesday, November 20th. Finally, KeyCorp assumed coverage on Surgery Partners in a research report on Friday, October 11th. They issued a "sector weight" rating for the company. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $36.56.

Get Our Latest Stock Analysis on Surgery Partners

About Surgery Partners

(Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

See Also

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Should you invest $1,000 in Surgery Partners right now?

Before you consider Surgery Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.

While Surgery Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Why Meta Is Still a Top Stock Pick for 2025

Why Meta Is Still a Top Stock Pick for 2025

Meta Platforms continues to shine as one of the strongest AI-driven companies heading into 2025. Learn why Meta is a solid pick for next year.

Related Videos

Why Amazon’s AI Power and Holiday Boost Make This Stock a 2025 Winner
Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines